Biospecimen strategy and operations at SCOPE 2027

Mar 1–4, 2027 Orlando, FL ~5k attendees Website

35 organizations at SCOPE 2027 present work in biospecimen strategy and operations: 23 technology and service providers, 10 drug developers and 2 academic, government and non-profit bodies. Between them they bring 106 presentations to the program. Most represented: Pfizer (20 on the program), Regeneron (19 on the program), Bristol Myers Squibb (19 on the program). As of Oct 17, 2026.

All 444 organizations at SCOPE 2027 →

Showing 1–3 of 35 organizations

Organization	SCOPE 2027 Attendance
Pfizer New York, NY
pfizer.com Large pharma Pharmaceutical company with medicines and vaccines in oncology, vaccines, inflammation and immunology, and internal medicine.	Panel Mon Mar 1 4:13pm–4:35pm KEYNOTE INTERACTIVE PANEL: SCOPE's 11th Annual Participant Engagement Awards Plenary · with Science 37, Patient Enrollment Advisors, Rapport Therapeutics +5 more Patient recruitment and engagement Panel Mon Mar 1 5:04pm–5:40pm KEYNOTE INTERACTIVE PANEL: Solving the Enrollment Crisis: Bridging Clinical Care and Clinical Research Plenary · with Tufts Center for the Study of Drug Development, AbbVie, AstraZeneca +1 more Patient recruitment and engagement Panel Tue Mar 2 9:15am–9:45am KEYNOTE INTERACTIVE PANEL: From Years to Months: Is Radical Acceleration in Clinical Research Finally Possible? Plenary · with Duke Clinical Research Institute, FDA, Bayer +2 more Trial design and delivery Talk Tue Mar 2 11:30am–11:55am 27 Years of Change: Why Human Behavior Is the Ultimate Variable in Scaling AI in Clinical Development AI in Clinical Research Talk Tue Mar 2 11:30am–11:55am The Potential of a Multimodal Endpoint: Integration of Digital Health Technologies (DHT)-Derived Measures with Clinical Assessments Digital Measures & eClinical Technologies Talk Tue Mar 2 3:05pm–3:30pm The Always-On Teammate: AI for Proactive Clinical Data Management Data AI in clinical research Panel Tue Mar 2 3:20pm–3:55pm From Signals to Endpoints: Designing and Scaling Composite and Multimodal Measures across Clinical Development Digital Measures & eClinical Technologies · with Digital Medicine Society (DiMe), BioMarin Pharmaceutical, Sanofi +1 more Panel Tue Mar 2 4:45pm–5:10pm AI-Powered RWD Approaches to Augment Clinical Trials Real World Evidence · with Parexel, GSK, University of California, Berkeley Panel Tue Mar 2 4:45pm–5:10pm AI-Ready Data Ecosystem Data · with Regeneron, Johnson & Johnson Talk Tue Mar 2 4:45pm–5:10pm Are We Collecting Too Much Data? Practical Approaches to Optimizing Data Collection Trial Design & Protocol Optimization · with Merck Panel Wed Mar 3 9:25am–9:50am Organizational Readiness for Tech-Enabled Trial Delivery Advancing Trial Delivery · with Astellas Pharma, Merck, Bristol Myers Squibb Talk Wed Mar 3 9:50am–10:15am No Sample Left Behind: Rewiring Biospecimen Management for Quality, Speed, and Visibility Biospecimen Strategy & Operations · with TruTechnologies Talk Wed Mar 3 11:40am–12:00pm Facilitating Statistical Programming with Agentic AI Data AI in clinical research Talk Wed Mar 3 11:40am–12:05pm The New Data Imperative: Critical Considerations for Today’s I&I Clinical Trials Therapeutic Area Spotlights Clinical data and real-world evidence Talk Wed Mar 3 12:17pm–12:30pm Orchestrating Pfizer's Next-Gen Statistical Environment: Bridging AI, Open Source, and Clinical Operations Data · with Posit Talk Wed Mar 3 2:35pm–2:50pm Evaluation Framework for Generative AI in Drug Development AI in Clinical Research Talk Wed Mar 3 3:25pm–3:50pm AssayFinder AI: An Agentic Platform for Transforming Assay Data into Searchable, Analysis-Ready Knowledge Data Talk Wed Mar 3 3:25pm–3:50pm Building AI Skills for Smarter Protocol Development: A Practical Approach to Protocol Optimization Trial Design & Protocol Optimization Panel Wed Mar 3 3:25pm–3:50pm From Data Noise to Decision: Making RBQM Work at Scale Plenary · with Roche, BeOne Medicines Quality, monitoring and safety Panel Wed Mar 3 3:25pm–3:50pm Operationalizing Imaging in Clinical Trials: A Best Practice Panel Discussion Digital Measures & eClinical Technologies · with Clinical Transformation Partners, GSK, AstraZeneca +1 more Talk Thu Mar 4 8:35am–9:00am Presentation on eCOA Implementation Best Practices across Solution Design, Project Management, Data Management, and Vendor Management Plenary Digital measures and eClinical technology
Regeneron Tarrytown, NY
regeneron.com Large pharma Biotechnology company developing and marketing antibody medicines in eye disease, immunology, oncology and other areas.	Talk Tue Mar 2 11:05am–11:30am A Smarter Approach to Multi-Study Supply Management Clinical Supply & Logistics Talk Tue Mar 2 11:30am–11:55am From People Running Systems to People Supported by AI: Mapping the Clinical Supply Landscape on the Road to an AI-Based Control Tower Clinical Supply & Logistics · with BC Consulting Group Talk Tue Mar 2 11:45am–11:55am Orchestrating a Multilingual Clinical Data Ecosystem: Bridging Operations and Analytics with AI and Open Source Data · with Posit Talk Tue Mar 2 3:30pm–3:55pm Unleashing DDF—Using Digital Protocols to Transform Clinical Trials Trial Design & Protocol Optimization Panel Tue Mar 2 4:45pm–5:10pm AI-Ready Data Ecosystem Data · with Johnson & Johnson, Pfizer Talk Wed Mar 3 9:00am–9:25am AI-Powered Trial Planning Feasibility & Site Strategy AI in clinical researchTrial design and delivery Talk Wed Mar 3 9:35am–9:50am Biomarker 360—Multimodal Biomarker Analytics to Accelerate Discovery and Decisions Biospecimen Strategy & Operations Talk Wed Mar 3 9:35am–9:50am SOP Assistant: Reimagining Procedural Document Management through AI-Powered Automation AI in Clinical Research Talk Wed Mar 3 11:40am–12:05pm From Survey Burden to Site Intelligence: Reimagining Clinical Trial Feasibility through AI-Powered Site Engagement Feasibility & Site Strategy Talk Wed Mar 3 12:05pm–12:30pm Decentralized Approaches to Strengthen Patient Retention Recruitment & Engagement Talk Wed Mar 3 12:05pm–12:30pm Meeting Sites Where They Are: What Happens When Sites Bring Their Own Technology Site Partnering, Engagement & Operations · with Sanofi, Eli Lilly Talk Wed Mar 3 2:35pm–3:00pm AI-Integrated Exploratory Data Analysis Framework for Rapid Visualization and Analyses of Clinical Trial Data Data Talk Wed Mar 3 2:35pm–3:00pm From Images to Endpoints: Building Best Practices to Optimizing Operations for Imaging in Clinical Trials Digital Measures & eClinical Technologies · with GSK, Clinical Transformation Partners Talk Wed Mar 3 2:50pm–3:00pm Beyond the Business Case: Building Credible ROI Models for AI in Clinical Research Operations AI in Clinical Research Talk Wed Mar 3 3:25pm–3:50pm Five Key Success Factors for Integrating AI into Clinical Analytics AI in Clinical Research Clinical data and real-world evidence Panel Wed Mar 3 4:12pm–4:42pm KEYNOTE INTERACTIVE PANEL: The Digital Transformation of Clinical Trials: From Protocol to Patient Plenary · with Johnson & Johnson, Takeda, Astellas Pharma +1 more Digital measures and eClinical technologyTrial design and delivery Talk Thu Mar 4 9:25am–9:50am AI-Enabled Trial Management with ATLAS Plenary AI in clinical researchTrial design and delivery Panel Thu Mar 4 12:20pm–12:55pm KEYNOTE INTERACTIVE PANEL: The New Clinical Development Operating Model Plenary · with Amgen, AstraZeneca, Ipsen Trial design and deliveryOutsourcing and budgeting
Bristol Myers Squibb Princeton, NJ
bms.com Large pharma Global pharmaceutical company with medicines in oncology, hematology, immunology, cardiovascular disease and neuroscience.	Talk Tue Mar 2 11:30am–11:55am Knowing the Risk Isn’t Enough: Building Enterprise Intelligence and Driving Action from Study-to-Asset Quality & Monitoring Talk Tue Mar 2 3:30pm–3:55pm From SOA to Budget: What AI-Enabled Study Budgeting Takes in Practice Budgeting & Resources Talk Tue Mar 2 3:30pm–3:55pm The Path to Touchless SAE Processing Safety & Pharmacovigilance Talk Tue Mar 2 3:55pm–4:20pm Preventing and Identifying Sample Overcollection through Dynamic Protocol-Guided Workflows Biospecimen Strategy & Operations · with TruTechnologies Panel Tue Mar 2 4:45pm–5:10pm The Financial Cost of AI in Clinical Development: Strategies for Scalable and Cost-Effective Deployment AI in Clinical Research · with Endpoint Clinical, Thermo Fisher Scientific, Genmab +2 more Talk Tue Mar 2 4:45pm–5:10pm The Future of Clinical Development: Integrating Trial Design, Feasibility, and Delivery Planning Feasibility & Site Strategy Talk Wed Mar 3 9:00am–9:20am The Self-Assembling Trial: How AI Is Rewiring Study Design and Orchestration AI in Clinical Research Talk Wed Mar 3 9:15am–9:35am How AI Makes Sense of Specimen Metadata Biospecimen Strategy & Operations Talk Wed Mar 3 9:25am–9:50am Bridging Evidence and Experience: AI-Powered Patient Insights from Trial Design to Labeling Trial Design & Protocol Optimization Panel Wed Mar 3 9:25am–9:50am Organizational Readiness for Tech-Enabled Trial Delivery Advancing Trial Delivery · with Pfizer, Astellas Pharma, Merck Panel Wed Mar 3 11:40am–12:05pm Cross-Functional Collaboration and Team Alignment Advancing Trial Delivery · with GSK, FDA, Novartis Talk Wed Mar 3 11:40am–12:05pm Transforming Biospecimen Oversight: A Risk-Based Framework for Sample Stability and Critical Handling Parameters Biospecimen Strategy & Operations Talk Wed Mar 3 12:05pm–12:30pm Intelligent Site Engagement: Using AI to Accelerate Feasibility, Streamline Site Activation, and Drive Site Success Feasibility & Site Strategy Talk Wed Mar 3 2:35pm–3:00pm Technology as an Enabler to Optimize Study Design and Protocol Development Trial Design & Protocol Optimization Panel Thu Mar 4 8:35am–9:00am Shared Challenges, Shared Solutions: Advancing Biospecimen Management across the Clinical Trial Ecosystem Plenary · with Yale Cancer Center, Merck, UPMC Hillman Cancer Center +1 more Biospecimen strategy and operations